SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1MEF - Registration adding securities to prior Form S-1 registration [Rule 462(b)]:
SEC Accession No. 0001213900-23-009573
Filing Date
2023-02-09
Accepted
2023-02-09 09:37:47
Documents
4
Effectiveness Date
2023-02-09

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea173059-s1mef_revelation.htm S-1MEF 29973
2 OPINION OF J.P. GALDA & CO. AS TO THE VALIDITY OF THE SHARES OF COMMON STOCK OF ea173059ex5-1_revelation.htm EX-5.1 17605
3 CONSENT OF BAKER TILLY US, LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF ea173059ex23-1_revelation.htm EX-23.1 1590
4 REGISTRATION FEE TABLE ea173059ex-fee_revelation.htm EX-FILING FEES 45561
  Complete submission text file 0001213900-23-009573.txt   95892
Mailing Address 4660 LAJOLLA VILLAGE DRIVE SUITE 100 SAN DIEGO CA 92122
Business Address 4660 LAJOLLA VILLAGE DRIVE SUITE 100 SAN DIEGO CA 92122 650-800-3717
REVELATION BIOSCIENCES, INC. (Filer) CIK: 0001810560 (see all company filings)

IRS No.: 843898466 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1MEF | Act: 33 | File No.: 333-269655 | Film No.: 23601651
SIC: 2834 Pharmaceutical Preparations